Expert Opinion on Therapeutic Patents This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An updated patent review of small-molecule ROS1 kinase inhibitors (2015 –2021)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 1, 2022 Category: Drugs & Pharmacology Authors: Meng Liu Jintian Dai Mudan Wei Qingshan Pan Wufu Zhu Source Type: research

Novel inhibitors of the STAT3 signaling pathway: an updated patent review (2014-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 1, 2022 Category: Drugs & Pharmacology Authors: Feng Wang Xin-Yu Cao Guo-Qiang Lin Ping Tian Dingding Gao Source Type: research

A patent review of ubiquitin-specific protease 7 (USP7) inhibitors (2014-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 31, 2022 Category: Drugs & Pharmacology Authors: Peng Li Ying Liu Hong-Min Liu Source Type: research

Dopamine D3 receptor ligands: a patent review (2014 –2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 24, 2022 Category: Drugs & Pharmacology Authors: Rita Maria Concetta Di Martino Andrea Cavalli Giovanni Bottegoni Source Type: research

Malaria transmission blocking compounds: a patent review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 11, 2022 Category: Drugs & Pharmacology Authors: Sara Consalvi Chiara Tammaro Federico Appetecchia Mariangela Biava Giovanna Poce Source Type: research

Small Molecule Inhibitors of Programmed Cell Death Ligand 1 (PD-L1): A Patent Review (2019 –2021)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 11, 2022 Category: Drugs & Pharmacology Authors: Jingjing Deng Zhengqi Cheng Juyang Long Alexander D ömling Micky Tortorella Yuanze Wang Source Type: research

Small molecules as kinetoplastid specific proteasome inhibitors for leishmaniasis: a patent review from 1998 to 2021
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 11, 2022 Category: Drugs & Pharmacology Authors: Mohd Imran Shah Alam Khan Abida Ahmed Subeh Alshrari Mahmoud Mudawi Eltahir Mudawi Mohammed Kanan Alshammari Aishah Ali Harshan Noufah Aqeel Alshammari Source Type: research

Menin-MLL protein-protein interaction inhibitors: a patent review (2014 –2021)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 11, 2022 Category: Drugs & Pharmacology Authors: Huanrong Bai San-Qi Zhang Hao Lei Fang Wang Mengyan Ma Minhang Xin Source Type: research

A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 10, 2022 Category: Drugs & Pharmacology Authors: Fernanda R. Rocho Vin ícius Bonatto Rafael F. Lameiro Jer ônimo Lameira Andrei Leit ão Carlos A. Montanari Source Type: research

Inhibitors of the GTPase KRASG12C in cancer: a patent review (2019-2021)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 22, 2022 Category: Drugs & Pharmacology Authors: Qifu Xu Guozhen Zhang Qian Liu Shunda Li Yingjie Zhang Source Type: research

Inhibitors of protease-activated receptor 4 (PAR4): a review of recent patents (2013 –2021)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 17, 2022 Category: Drugs & Pharmacology Authors: Xiangying Yu Shanshan Li Xiong Zhu Yi Kong Source Type: research

Discovery of small-molecule ATR inhibitors for potential cancer treatment: a patent review from 2014 to present
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 14, 2022 Category: Drugs & Pharmacology Authors: Suwen Hu Zi Hui Jilong Duan Carmen Garrido Tian Xie Xiang-Yang Ye Source Type: research

Selective TYK2 inhibitors as potential therapeutic agents: a patent review (2019 –2021)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 31, 2022 Category: Drugs & Pharmacology Authors: Felix Gonzalez Lopez de Turiso Kevin Guckian Source Type: research

PDE1 inhibitors: a review of the recent patent literature (2008-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 31, 2022 Category: Drugs & Pharmacology Authors: Mei-Ling Le Mei-Yan Jiang Chuan Han Yi-Yi Yang Yinuo Wu Source Type: research

Synthetic methodologies and PET imaging applications of fluorine-18 radiotracers: a patent review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 28, 2022 Category: Drugs & Pharmacology Authors: Sridhar Goud Nerella Ahana Bhattacharya Pavitra S Thacker Sanam Tulja Source Type: research